However, the meta-analysis by Baretta et al. on breast cancer survival in carriers of BRCA1/BRCA2 mutations included 60 studies with the number of mutation carriers ranging from 5 to 326 (median, 39.5) [27]. This evidence concerns the gene BRCA2 and breast cancer.